Ivan Boroznyak

R-Pharm

R-Pharm – Russian high-tech pharmaceutical enterprise, successfully transformed from distribution to a fully vertically integrated specialty pharma player. ■Founded in 2001 in Moscow, fully private; ■Employs over 3500 highly qualified specialists, has 50+ branches at 9 countries; ■Products from a broad number of therapeutic areas in specialty/hospital care; ■RUR 74,1 B revenue in 2015. Key areas of R-Pharm's competence include: manufacturing of finished drugs and APIs, R&D of innovative medicines and technologies, training and education for industry and health care specialists, venture investments in promising scientific data and research, cooperation with major international pharmaceutical companies and international universities in the field of drug development and combined clinical trials in Russia. Since foundation not less than 85% of profits reinvested into infrastructure and products development. R-Pharm group's mission is to contribute to professional advancement of healthcare specialists, to bring affordable efficient pharmaceutical products to patients, ensure the product quality at each R&D and production level and encourage the innovative approach in healthcare problems solving.